Dermatend Availability in Pakistan: Not Approved, Not for Sale

Regulatory Status of Dermatend in Pakistan

Dermatend (a skin graft substitute / dermal regeneration template) is not approved by the Drug Regulatory Authority of Pakistan (DRAP) for marketing or clinical use.

Implications

• Not commercially available in any pharmacy, hospital supply chain, or authorized distributor.
• Cannot be legally imported for sale or prescription use without DRAP registration.
• No local pricing exists because the product has no market authorization.

Alternatives in Pakistan

For burn/wound coverage, Pakistani surgeons use:

• Autografts (patient's own skin).
• Allografts (cadaver skin – via tissue banks).
• Other approved dermal substitutes (e.g., Integra, Matriderm – if registered).
• Advanced dressings (hydrocolloids, alginates, silver-impregnated).

Action for Patients/Providers

Consult a qualified plastic/burn surgeon in Pakistan for approved treatment options. Do not attempt to source unregistered products personally—risks include counterfeit, improper storage, legal issues, and lack of medical oversight.